0.74
price down icon3.90%   -0.03
 
loading
전일 마감가:
$0.77
열려 있는:
$0.7705
하루 거래량:
211.70K
Relative Volume:
0.05
시가총액:
$6.61M
수익:
-
순이익/손실:
$-13.28M
주가수익비율:
-0.1612
EPS:
-4.5911
순현금흐름:
$-8.99M
1주 성능:
-7.50%
1개월 성능:
+15.81%
6개월 성능:
-70.52%
1년 성능:
-97.99%
1일 변동 폭
Value
$0.74
$0.79
1주일 범위
Value
$0.7348
$0.8449
52주 변동 폭
Value
$0.3015
$65.00

Gri Bio Inc Stock (GRI) Company Profile

Name
명칭
Gri Bio Inc
Name
전화
(619) 400-1171
Name
주소
2223 AVENIDA DE LA PLAYA, LA JOLLA
Name
직원
4
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
GRI's Discussions on Twitter

GRI을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
GRI
Gri Bio Inc
0.74 6.61M 0 -13.28M -8.99M -30.28
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
397.27 102.31B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
701.85 77.13B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
623.82 37.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
245.44 31.66B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.08 27.11B 3.30B -501.07M 1.03B -2.1146

Gri Bio Inc Stock (GRI) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-09 개시 H.C. Wainwright Buy

Gri Bio Inc 주식(GRI)의 최신 뉴스

pulisher
Dec 10, 2024

GRI Bio (NASDAQ:GRI) Now Covered by HC Wainwright - Defense World

Dec 10, 2024
pulisher
Dec 09, 2024

GRI Bio Inc (NASDAQ: GRI): What’s Next After The Stock Plunge? - Stocks Register

Dec 09, 2024
pulisher
Dec 09, 2024

Astera Labs Inc: Is ALAB Stock Worth Buying? - Stocks Register

Dec 09, 2024
pulisher
Dec 09, 2024

HC Wainwright & Co. Initiates Coverage of GRI Bio (GRI) with Buy Recommendation - MSN

Dec 09, 2024
pulisher
Dec 06, 2024

GRI Bio to Participate in the Virtual Investor Closing Bell Series - GlobeNewswire

Dec 06, 2024
pulisher
Dec 06, 2024

GRI Bio to Present Corporate Strategy at Virtual Investor Closing Bell Series - StockTitan

Dec 06, 2024
pulisher
Nov 21, 2024

GRI Bio reports progress in IPF treatment with GRI-0621 - Investing.com India

Nov 21, 2024
pulisher
Nov 21, 2024

GRI Bio Showcases GRI-0621’s Potential to Reduce - GlobeNewswire

Nov 21, 2024
pulisher
Nov 21, 2024

GRI Bio's IPF Drug Shows Promise in Preclinical Data, Phase 2a Trial Underway | GRI Stock News - StockTitan

Nov 21, 2024
pulisher
Nov 21, 2024

GRI Bio Showcases GRI-0621's Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF) - The Manila Times

Nov 21, 2024
pulisher
Nov 20, 2024

GRI Bio files to sell 1.58M shares of common stock for holders - MSN

Nov 20, 2024
pulisher
Nov 15, 2024

SEC Form 424B3 filed by GRI Bio Inc. - Quantisnow

Nov 15, 2024
pulisher
Nov 15, 2024

GRI Bio Inc (GRI) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 14, 2024

GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

GRI Bio Raises $13.9M, Extends Runway for Key IPF Drug Trial Data in 2025 | GRI Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 08, 2024

GRI Bio Inc expected to post a loss of 73 cents a shareEarnings Preview - XM

Nov 08, 2024
pulisher
Nov 04, 2024

Ascendiant Capital Initiates Coverage of GRI Bio (GRI) with Buy Recommendation - MSN

Nov 04, 2024
pulisher
Nov 01, 2024

Curis (CRIS) Stock Plummets Over 5% Amid Lack of Institutional R - GuruFocus.com

Nov 01, 2024
pulisher
Oct 31, 2024

Capricor Therapeutics (CAPR) Faces 5% Drop Amid Industry Slump - GuruFocus.com

Oct 31, 2024
pulisher
Oct 28, 2024

Primary Sclerosing Cholangitis Pipeline 2024: Clinical Trials - openPR

Oct 28, 2024
pulisher
Oct 25, 2024

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80% - MSN

Oct 25, 2024
pulisher
Oct 25, 2024

GRI Bio secures funding to advance IPF treatment into 2025 - Investing.com India

Oct 25, 2024
pulisher
Oct 24, 2024

GRI Bio secures funding to advance IPF treatment into 2025 By Investing.com - Investing.com UK

Oct 24, 2024
pulisher
Oct 24, 2024

GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024 - GlobeNewswire

Oct 24, 2024
pulisher
Oct 23, 2024

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Oct 23, 2024
pulisher
Oct 22, 2024

Dow Falls Over 150 Points; General Motors Tops Q3 Views - Benzinga

Oct 22, 2024
pulisher
Oct 22, 2024

Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 22, 2024
pulisher
Oct 21, 2024

U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.80% - MSN

Oct 21, 2024
pulisher
Oct 21, 2024

GRI Bio Announces Exercise of Warrants - GlobeNewswire

Oct 21, 2024
pulisher
Oct 21, 2024

Dyne Therapeutics (DYN) Shares Plummet Amid Market Volatility - GuruFocus.com

Oct 21, 2024
pulisher
Oct 21, 2024

Top Innovation Stocks Surge: PRSO, SYTA, SAVE, ISPC, GRI, BIVIMust-Watch Stocks This Week - openPR

Oct 21, 2024
pulisher
Oct 21, 2024

Energy storage ‘key’ to sustainability – report - Yahoo! Voices

Oct 21, 2024
pulisher
Oct 21, 2024

As iPhone Sales Soar in China, Is It Time to Buy Apple Stock? - Yahoo! Voices

Oct 21, 2024
pulisher
Oct 21, 2024

2 Artificial Intelligence (AI) Stocks That Are No-Brainer Buys - Yahoo! Voices

Oct 21, 2024
pulisher
Oct 21, 2024

Statkraft seeks approval for 2.1GW offshore wind farm in Baltic Sea - Yahoo! Voices

Oct 21, 2024
pulisher
Oct 21, 2024

BioPorto A/S Announces Changes to the US Commercial Organization - Yahoo Finance

Oct 21, 2024
pulisher
Oct 21, 2024

CRISPR-based Gene Editing Market Report 2024-2030, Featuring Revvity, Danaher, GenScript, Merck, Tocris Bioscience, OriGene Technologies, Bio-Rad Laboratories, Bio-Techne & New England Biolabs - Yahoo Finance

Oct 21, 2024
pulisher
Oct 21, 2024

bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement - Yahoo Finance

Oct 21, 2024
pulisher
Oct 21, 2024

Health Canada approves Arcutis’ ZORYVE foam for seborrheic dermatitis - Yahoo! Voices

Oct 21, 2024
pulisher
Oct 21, 2024

Amcor reports 9% drop in greenhouse gas emissions in 2024 - Yahoo! Voices

Oct 21, 2024
pulisher
Oct 21, 2024

Esso Australia completes Kipper Compression Project - Yahoo! Voices

Oct 21, 2024
pulisher
Oct 21, 2024

Final countdown: 7 days until TechCrunch Disrupt 2024 kicks off - Yahoo! Voices

Oct 21, 2024
pulisher
Oct 21, 2024

Cigna and Humana re-engage in merger talks - Yahoo! Voices

Oct 21, 2024
pulisher
Oct 21, 2024

Starr Insurance to operate in Seoul, South Korea - Yahoo! Voices

Oct 21, 2024
pulisher
Oct 21, 2024

Alliance Group gets insurance intermediary licence in Germany - Yahoo! Voices

Oct 21, 2024
pulisher
Oct 21, 2024

PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance

Oct 21, 2024
pulisher
Oct 21, 2024

Live Oak Ventures Participates in Financing of Synply, Inc. - Yahoo Finance

Oct 21, 2024
pulisher
Oct 21, 2024

US Stocks Edge Lower; Dow Falls 50 Points - Benzinga

Oct 21, 2024
pulisher
Oct 21, 2024

T-Mobile partnership has this beaten down stock launching 🚀 - RagingBull

Oct 21, 2024
pulisher
Oct 21, 2024

2 Artificial Intelligence (AI) Stocks That Could Make You a Millionaire - Yahoo! Voices

Oct 21, 2024
pulisher
Oct 21, 2024

Are Medical Stocks Lagging BioLife Solutions (BLFS) This Year? - Yahoo Finance

Oct 21, 2024

Gri Bio Inc (GRI) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
자본화:     |  볼륨(24시간):